as semi retired and xc_mcse and a few other members have...

as semi retired and xc_mcse and a few other members have mentioned , a partnership for european rights with a powerhouse like medtronic can provide SSH with a huge leap

here are a few advantages

1- provide SSH with the powerful sales and marketing tools to sell more cpulse + gain worldwide traction
2- more than enough cash to last beyond the trial and take the company from a micro cap to a midcap opening the doors for bigger funds and institutions to have a holding in SSH.
3- huge sales in europe will be accelerated x10 compared to ssh selling the product alone
4- huge success in europe will help the us pivotal trial as prospective patients would believe in the device and its success
5- stock price would be on an uptrend to 100+


thought it would be a good topic to discuss and also look at the pros of such a deal , and the cons if there are any